Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | USP7 | Q93009 | 2/20 | 0.39 |
| ▸ | USP8 | P40818 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | USP47 | Q96K76 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22109074 | 0.89 | MAPT (0.38) | MAPTPKMALDH1A1GAAMEN1 | |
| SCHEMBL22109491 | 0.86 | MAPT (0.42) | MAPTPKMALDH1A1GAAUSP7 | |
| SCHEMBL22109132 | 0.78 | MAPT (0.39) | MAPTPKMALDH1A1GAAMEN1 | |
| SCHEMBL22109223 | 0.78 | MAPT (0.46) | MAPTPKMALDH1A1GAAMEN1 | |
| SCHEMBL22109485 | 0.76 | USP8 (0.31) | MAPTPKMALDH1A1GAAUSP7 | |
| SCHEMBL22109220 | 0.75 | MAPT (0.46) | MAPTPKMALDH1A1GAAUSP7 | |
| SCHEMBL22109130 | 0.75 | MAPT (0.39) | MAPTPKMALDH1A1GAAUSP7 | |
| SCHEMBL22109421 | 0.74 | MAPT (0.40) | MAPTPKMALDH1A1GAAMEN1 | |
| SCHEMBL21917286 | 0.72 | MAPT (0.43) | MAPTPKMALDH1A1GAAUSP7 | |
| SCHEMBL24958991 | 0.67 | USP8 (0.43) | MAPTPKMALDH1A1GAAUSP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767299-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2023-09-26 | — | — | US | disclosed |
| US-11767299-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2023-09-26 | — | — | US | disclosed |
| US-20200190039-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200190039-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | L1CAM, EFNA1, EPCAM | MAPT 1878/4885PKM 1122/4885ALDH1A1 33/4885 |
| US-11767299-B2 | Materials for organic electroluminescent devices | L1CAM, EFNA1, EPCAM | MAPT 1878/4885PKM 1122/4885ALDH1A1 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.